TrialHuman vaccines & immunotherapeutics2018

Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An open, phase III, non-randomized, multi-center study.

Martina Kovac et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.